News for Sangamo BioSciences, Inc. (SGMO)

News for Sangamo BioSciences, Inc.
Date Headline
Feb 24, 2017 05:11 PM SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb 21, 2017 04:03 PM Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast
Feb 08, 2017 04:03 PM Sangamo Therapeutics Announces Upcoming Presentations At The 13th Annual WORLDSymposiumâ„¢ Meeting
Jan 20, 2017 01:59 PM ETFs with exposure to Sangamo Therapeutics, Inc. : January 20, 2017
Jan 18, 2017 01:04 PM SANGAMO THERAPEUTICS, INC Financials
Jan 13, 2017 09:23 AM Biotech Premarket Movers: SGMO, IPXL, PTLA
Jan 11, 2017 09:08 AM Biotech Premarket Movers: IPXL, SGMO, ARLZ
Jan 11, 2017 07:30 AM Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-318 Genome Editing Treatment for MPS I
Jan 10, 2017 08:00 AM Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering
Jan 06, 2017 08:16 AM SANGAMO BIOSCIENCES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia